Observational study that will analyse the spread and stratification of lung cancer risk using artificial intelligence

Trial Identifier:	D133FR00226
Sponsor:	AstraZeneca
Start Date:	July 2026
Primary Completion Date:	August 2027
Study Completion Date:	August 2027
Condition:	Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Brazil	São Paulo, Brazil

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.